- Home
- Middle East And Africa At Home Testing Kits Market

Middle East and Africa At-Home Testing Kits Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-66 | No of pages: 130 | Format:
Middle East and Africa at-home testing kits market is projected to register a CAGR of 3.7% in the forecast period of 2021 to 2028. The new market report contains data for historic year 2019, the base year of calculation is 2018 and the forecast period is 2021 to 2028.
Market Segmentation
Middle East and Africa At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit and Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Other Form Types), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of the at-home testing kits market are:
Rising adoption of self-testing kits helps in reducing hospital expenses.
Increasing awareness towards the importance of HIV.
Market Players
Some of the major players operating in the at-home testing kits market are:
Abbott
BD
Cardinal Health
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Bionime Corporation
SA Scientific
ARKRAY USA, Inc.
Nova Biomedical
Eurofins Viracor, Inc.
TaiDoc Technology Corporation
Drgerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd.
Atomo Diagnostics
RUNBIO BIOTECH CO.,LTD
Mylan N.V. (A Subsidiary of Viatris Inc)
MP BIOMEDICALS
VedaLab
Ascensia Diabetes Care Holdings AG
TABLE OF CONTENT
Segmentation
Short Description
Middle East and Africa At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit and Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Other Form Types), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Definition
At-home testing kits means testing instruments which help person to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide the person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, infectious diseases such as malaria, COVID-19 and others. For performing these rapid at-home tests, blood, urine and oral fluid can be taken as a sample.
Market Segmentation
The at-home testing kits market is segmented into six notable segments which are based on the test type, type, age, sample type, usage and distribution channels.
On the basis of test type, the at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types.
On the basis of type, the at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card and other form types.
On the basis of age, the at-home testing kits market is segmented into pediatric, adult and geriatric.
On the basis of sample type, the at-home testing kits market is segmented into urine, blood, saliva and other sample types.
On the basis of usage, the at-home testing kits market is segmented into disposable and reusable.
On the basis of distribution channels, the at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket and online pharmacies.
Market Players
Some of the major players operating in the at-home testing kits market are:
Abbott
BD
Cardinal Health
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Bionime Corporation
SA Scientific
ARKRAY USA, Inc.
Nova Biomedical
Eurofins Viracor, Inc.
TaiDoc Technology Corporation
Drgerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd.
Atomo Diagnostics
RUNBIO BIOTECH CO.,LTD
Mylan N.V. (A Subsidiary of Viatris Inc)
MP BIOMEDICALS
VedaLab
Ascensia Diabetes Care Holdings AG
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.